Current stage?-Stage II - Page 29 of 30 Posts on Medivizor
Navigation Menu

Current stage?-Stage II Posts on Medivizor

Rising PSA levels after radiation treatment can predict prostate cancer mortality

Rising PSA levels after radiation treatment can predict prostate cancer mortality

Posted by on Feb 25, 2013 in Prostate cancer | 0 comments

In a nutshell This article evaluated whether the interval to biochemical failure (IBF) can be used as a prediction factor for prostate cancer mortality. The IBF was found to be the best current predictor of prostate cancer mortality in patients previously treated with radiation therapy. Some background Biochemical failure is defined...

Read More

Benefits of postoperative chemotherapy vary according to breast cancer type

Benefits of postoperative chemotherapy vary according to breast cancer type

Posted by on Feb 25, 2013 in Breast cancer | 0 comments

In a nutshell This study questioned the benefit of adding chemotherapy to postoperative hormonal treatment in the case of lobular breast cancer. Their findings were that chemotherapy seems to offer no additional beneficial effects in women with lobular breast cancer receiving hormonal therapy. Some background There are two main types of breast...

Read More

The use of systemic chemotherapy for patients with poorly differentiated and signet cell adenocarcinoma of the appendix

The use of systemic chemotherapy for patients with poorly differentiated and signet cell adenocarcinoma of the appendix

Posted by on Feb 24, 2013 in Colorectal cancer | 0 comments

In a nutshell The present study evaluated the effects of systemic chemotherapy and cytoreductive surgery (CRS) on survival in patients with aggressive types of cancer of the appendix (poorly differentiated and signet ring cell adenocarcinoma). The main findings were that systemic chemotherapy appears to be a viable treatment option for these types of...

Read More

Focal Ultrasound-based therapy for prostate cancer as means to reduced genito-urinary side effects

Focal Ultrasound-based therapy for prostate cancer as means to reduced genito-urinary side effects

Posted by on Feb 24, 2013 in Prostate cancer | 0 comments

In a nutshell This study evaluated whether focal Ultrasound-based therapy of individual cancer lesions can minimize the side effects associated with radical therapy that involves the whole prostate gland. Main findings: Focused therapy directed into cancer tissues significantly reduces genitourinary side effects like urine-leakage and impotence. Some...

Read More

Does Tamoxifen reduce the risk of cancer in a second breast in BRCA1 and BRCA2 carriers?

Does Tamoxifen reduce the risk of cancer in a second breast in BRCA1 and BRCA2 carriers?

Posted by on Feb 24, 2013 in Breast cancer | 0 comments

In a nutshell The risk of breast cancer is high (~80%) in women who inherit a damaged (mutated) gene called BRCA1 or BRCA 2 (‘BRCA carriers’). Following the first diagnosis, their risk of developing another tumor in the second breast within 10 years is 30%. Some background Some types of breast cancer need estrogen (female sex...

Read More

Prostatectomy and radiation effects on urinary, bowel and erectile dysfuntion 2, 5 and 15 years after prostate cancer diagnosis

Prostatectomy and radiation effects on urinary, bowel and erectile dysfuntion 2, 5 and 15 years after prostate cancer diagnosis

Posted by on Feb 24, 2013 in Prostate cancer | 0 comments

In a nutshell This paper evaluated the long-term influence of prostate cancer treatment with prostatectomy or radiotherapy on urinary, bowel and sexual function. Prostatectomy was associated with a higher rate of urinary and erectile dysfunction, whereas radiotherapy caused more frequent bowel urgency at 2 and 5 years after diagnosis. Some background...

Read More

A new biomarker panel for the assessment of prostate cancer recurrence risk

A new biomarker panel for the assessment of prostate cancer recurrence risk

Posted by on Feb 24, 2013 in Prostate cancer | 0 comments

In a nutshell The present study evaluated a new biomarker that could be used to predict recurrence of prostate cancer after surgical removal of the prostate gland (prostatectomy). Three proteins called Sp1/Sp3/FLIP, combined with the Gleason score were found highly prognostic in the prediction of recurrence, and can therefore help guiding the initial...

Read More